Atrial tachycardia: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
*Electrical focus that originates outside in the sinus node at a single location | *Electrical focus that originates outside in the sinus node at a single location | ||
**By comparison, reentrant tachycardias (eg. AVRT, AVNRT) involve multiple foci/ larger circuits | **By comparison, reentrant tachycardias (eg. AVRT, AVNRT) involve multiple foci/ larger circuits | ||
*Sustained atrial tachycardia can lead to a tachycardia-induced cardiomyopathy and it is important not to misdiagnose the rhythm as [[sinus tachycardia]] in such cases. | |||
==Clinical Features== | ==Clinical Features== | ||
*Often asymptomatic | |||
*[[Palpitations]] | *[[Palpitations]] | ||
** | **Non-specific finding | ||
** | **Associated with all tachydysrhythmias, not just AT | ||
** | **Rapid fluttering/throbbing/pounding sensation in the chest or neck | ||
*[[Syncope]] | *[[Syncope]] | ||
** | **Patients with AT rarely present with syncope | ||
** | **Cerebral hypoperfusion is more common with a ventricular rate >200 bpm | ||
*[[Chest pain]] | *[[Chest pain]] | ||
** | **Can present if there is underlying cardiovascular disease | ||
** | **Represents a worsening of the associated disease | ||
*[[Dyspnea]] | *[[Dyspnea]] | ||
** | **Can present if there is underlying cardiovascular disease | ||
** | **Represents a worsening of the associated disease | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
| Line 34: | Line 36: | ||
==Management== | ==Management== | ||
===Unstable=== | |||
* | *[[Cardioversion]] | ||
* | ===Stable=== | ||
*If digoxin toxicity | *May cardiovert with [[adenosine]] or with [[beta blockers]] | ||
* | *If [[digoxin toxicity]], stop drug and consider [[Digibind]] | ||
*[[Beta blocker]] or [[calcium channel blocker]] for rate control and/or prophylaxis against recurrent episodes | |||
==See Also== | ==See Also== | ||
Revision as of 22:23, 27 February 2021
Background
- Also known as focal atrial tachycardia
- Rate >100 bpm
- Electrical focus that originates outside in the sinus node at a single location
- By comparison, reentrant tachycardias (eg. AVRT, AVNRT) involve multiple foci/ larger circuits
- Sustained atrial tachycardia can lead to a tachycardia-induced cardiomyopathy and it is important not to misdiagnose the rhythm as sinus tachycardia in such cases.
Clinical Features
- Often asymptomatic
- Palpitations
- Non-specific finding
- Associated with all tachydysrhythmias, not just AT
- Rapid fluttering/throbbing/pounding sensation in the chest or neck
- Syncope
- Patients with AT rarely present with syncope
- Cerebral hypoperfusion is more common with a ventricular rate >200 bpm
- Chest pain
- Can present if there is underlying cardiovascular disease
- Represents a worsening of the associated disease
- Dyspnea
- Can present if there is underlying cardiovascular disease
- Represents a worsening of the associated disease
Differential Diagnosis
Narrow-complex tachycardia
- Regular
- AV Node Independent
- Sinus tachycardia
- Atrial tachycardia (uni-focal or multi-focal)
- Atrial fibrillation
- Atrial flutter
- Idiopathic fascicular left ventricular tachycardia
- AV Node Dependent
- AV Node Independent
- Irregular
- Multifocal atrial tachycardia (MAT)
- Sinus tachycardia with frequent PACs, PJCs, PVCs
- Atrial fibrillation
- Atrial flutter with variable conduction
- Digoxin Toxicity
Evaluation
Workup
Diagnosis
- Atrial tachycardia differs from sinus tachycardia in that the impulses are generated by an ectopic focus somewhere within the atrial myocardium rather than the sinus node.
- The atrial (P wave), is usually 100-250 /min with abnormally shaped P waves. The combination of focal atrial tachycardia with AV block is particularly common in digoxin toxicity.
- Multifocal atrial tachycardia can be mistaken for AF, due to its irregular nature, but closer inspection of the ECG will reveal P waves with at least three different morphologies.
Management
Unstable
Stable
- May cardiovert with adenosine or with beta blockers
- If digoxin toxicity, stop drug and consider Digibind
- Beta blocker or calcium channel blocker for rate control and/or prophylaxis against recurrent episodes
